Furthermore, in the case of ZES/MEN1 patients, the controversial role of surgery or the type of surgery in these patients for the gastrinomas or NF-pNET will complicate the design of any study to address the other controversial issues in these patients discussed here. The gene discussed is MEN1; the disease is gastrin-producing neuroendocrine tumor.